Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Previous reviews have focused on the use of L
The GIPR/GLP-1R/GCGR tri-agonist LY3437943 has been compared with dulaglutide 1.5 mg and placebo in a Phase I study in individuals with type 2 diabetes [51]
Five food logging methods keep meals easy to record
doi: 10.1002/hep.21131 79 ShanS.ShenZ.SongF
The generation of mutants for selected genes based on transcriptomic data, using advanced techniques such as CRISPR/Cas9, will further open new horizons for developing resistance to viruses or other multifactorial stresses
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
US$ 24.93
US$ 27.21
US$ 28.06
US$ 21.55
US$ 28.33
US$ 25.82
US$ 28.55
US$ 22.61
US$ 29.16
US$ 22.51
US$ 27.24
US$ 21.03
